Literature DB >> 12498119

[Connection between severity of the course of tick-borne encephalitis with the concentration of interleukin-2 and interleukin-6 in blood].

A V Timofeev, Iu Iu Kondrat'eva, V G Orlovskiĭ, G P Kurzhukov, V B Loktev, G G Karganova.   

Abstract

AIM: To test IL-6 and IL-2 serum concentrations as indirect prognostic indicators in tick-borne encephalitis (TBE) course.
MATERIAL AND METHODS: 13 TBE patients' sera were examined for IL-2 and IL-6.
RESULTS: IL-6 was not detected in patients with TBE fever but was detected in meningoencephalytic TBE.
CONCLUSION: TBE patients demonstrate a positive correlation between the disease severity and serum IL-6. This criterion is proposed as a prognostic factor of a TBE course.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12498119

Source DB:  PubMed          Journal:  Ter Arkh        ISSN: 0040-3660            Impact factor:   0.467


  4 in total

1.  Comparative analysis of immune responses to Russian spring-summer encephalitis and Omsk hemorrhagic fever viruses in mouse models.

Authors:  Bersabeh Tigabu; Terry Juelich; Michael R Holbrook
Journal:  Virology       Date:  2010-09-28       Impact factor: 3.616

2.  Serum levels of interleukin 6 in recently hospitalized tick-borne encephalitis patients correlate with age, but not with disease outcome.

Authors:  M G Toporkova; S E Aleshin; S V Ozherelkov; M V Nadezhdina; J R Stephenson; A V Timofeev
Journal:  Clin Exp Immunol       Date:  2008-06       Impact factor: 4.330

3.  Lethal Experimental Tick-Borne Encephalitis Infection: Influence of Two Strains with Similar Virulence on the Immune Response.

Authors:  Anastasia S Shevtsova; Oxana V Motuzova; Vera M Kuragina; Nelli K Akhmatova; Larissa V Gmyl; Yaroslava I Kondrat'eva; Liubov I Kozlovskaya; Yulia V Rogova; Alexander G Litov; Lidiya Iu Romanova; Galina G Karganova
Journal:  Front Microbiol       Date:  2017-01-20       Impact factor: 5.640

4.  Cytokines and chemokines profile in encephalitis patients: A meta-analysis.

Authors:  Alireza Soltani Khaboushan; Mohammad-Taha Pahlevan-Fallahy; Parnian Shobeiri; Antônio L Teixeira; Nima Rezaei
Journal:  PLoS One       Date:  2022-09-01       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.